Literature DB >> 9018002

Assessing the eligibility for liver transplantation of patients with fulminant hepatitis.

S Uetsuji1, H Komada, A H Kwon, Y Kamiyama, Y Uedono, T Tanaka.   

Abstract

The spleen to liver volume (S/L) ratio of 13 patients with fulminant hepatitis was determined using X-ray computed tomography (CT), and the correlation between S/L ratio and prognosis was evaluated. The S/L ratio of 6 patients who died was greater than 0.16, whereas that of the remaining 7 patients who survived was less than 0.15. These findings suggest that determining the S/L ratio using CT may be useful for assessing the eligibility of patients with fulminant hepatitis for liver transplantation.

Entities:  

Mesh:

Year:  1997        PMID: 9018002     DOI: 10.1007/bf02385914

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  5 in total

1.  [Clinical evaluation of the measurement of hepatosplenic volume ratio by computed tomography].

Authors:  S Uetsuji; M Yamamura; H Komada; Y Okuda; K Yamamichi; K Hioki; M Yamamoto
Journal:  Nihon Geka Gakkai Zasshi       Date:  1992-02

2.  Liver transplantation for fulminant hepatic failure.

Authors:  S Iwatsuki; C O Esquivel; R D Gordon; B W Shaw; T E Starzl; R R Shade; D H Van Thiel
Journal:  Semin Liver Dis       Date:  1985-11       Impact factor: 6.115

3.  Fulminant hepatic failure with massive necrosis as a result of hepatitis A infection.

Authors:  C T Masada; B W Shaw; R K Zetterman; S S Kaufman; R S Markin
Journal:  J Clin Gastroenterol       Date:  1993-09       Impact factor: 3.062

4.  Determination of the integrated CT number of the whole liver in patients with severe hepatitis: as an indicator of the functional reserve of the liver.

Authors:  T Kumahara; Y Muto; H Moriwaki; T Yoshida; E Tomita
Journal:  Gastroenterol Jpn       Date:  1989-06

5.  Liver transplantation in European patients with the hepatitis B surface antigen.

Authors:  D Samuel; R Muller; G Alexander; L Fassati; B Ducot; J P Benhamou; H Bismuth
Journal:  N Engl J Med       Date:  1993-12-16       Impact factor: 91.245

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.